Ignite Creation Date:
2025-12-25 @ 1:20 AM
Ignite Modification Date:
2025-12-25 @ 11:29 PM
Study NCT ID:
NCT06216093
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-06-15
First Post:
2024-01-02
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase I, First-In Human Study to Evaluate Safety and Tolerability of EuRSV in Healthy Adults Aged Between 19 Years and 80 Years
Sponsor:
EuBiologics Co.,Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-05-08
Start Date Type:
ACTUAL
Primary Completion Date:
2025-07-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-09-30
Completion Date Type:
ESTIMATED
First Submit Date:
2024-01-02
First Submit QC Date:
None
Study First Post Date:
2024-01-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-12
Last Update Post Date:
2025-06-15
Last Update Post Date Type:
ACTUAL